Blood pressure regulation by endocannabinoids and their receptors
- 19 February 2005
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 48 (8) , 1130-1138
- https://doi.org/10.1016/j.neuropharm.2004.12.005
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 2004
- CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarctionBritish Journal of Pharmacology, 2003
- Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric arteryBritish Journal of Pharmacology, 2003
- Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?British Journal of Pharmacology, 2003
- Anandamide-Induced Depressor Effect in Spontaneously Hypertensive RatsHypertension, 2003
- Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated heartsBritish Journal of Pharmacology, 2002
- Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptorsLife Sciences, 1997
- Mechanism of the Hypotensive Action of Anandamide in Anesthetized RatsHypertension, 1996
- A cannabinoid with cardiovascular activity but no overt behavioral effectsCellular and Molecular Life Sciences, 1977
- Effect of Δ9-tetrahydrocannabinol on experimental hypertension in ratsJournal of Pharmacy and Pharmacology, 1975